The global Digital Psychotherapeutics Market size is projected to be worth USD 1.06 billion in 2023. Over the next ten years, global digital psychotherapeutics demand is likely to accelerate at 27.6% CAGR. By 2033, the total market value is expected to surpass USD 12.2 billion.
People living in various regions of the world experience difficulties accessing mental health treatments on time. This is due to shortage of face-to-face psychotherapy services and high healthcare costs.
The rise of digital psychotherapy as an alternative treatment delivery method is filling this gap. By digitizing and innovating in psychological therapies, providers can allow patients to access health services from remote locations. This helps consumers by reducing waiting list time and healthcare costs.
Digital psychotherapeutics refers to mental health aid delivery through electronic devices that involve the use of internet. It can also be called e-therapy, e-counseling, or online counseling.
Digital psychotherapeutics involves the treatment of behavioral, emotional, personality, and psychiatric disorders through verbal and nonverbal communication and interventions. Digital and internet-based health technologies are experiencing high demand in this field over recent years. Research suggests this has spurred change in patient behavior and positively affected prognosis.
Digital psychotherapeutics can be used as a standalone treatment or in conjunction with other conventional treatments such as in-person or pharmacological therapy. Various studies have revealed that digital psychotherapy, especially cognitive behavioral therapy, can be as effective as face-to-face psychotherapy.
Mental health problems not only affect a person emotionally but physically as well. Various treatment options such as drugs and non-drug treatment are available for these mental disorders.
Psychiatric medications are associated with several side effects including nausea, headache, dizziness, sexual problems, nausea, constipation, etc. As a result, people are gradually shifting their preference towards psychotherapy, including digital psychotherapeutics.
Digital psychotherapeutics offers various benefits including low cost and easy accessibility. Rising awareness about the benefits associated with digital psychotherapeutics is expected to boost the market.
The COVID-19 pandemic, which contributed to mental health risk factors such as widespread isolation and chronic stress, has raised the prevalence of substance use disorders (SUDs). Digital psychotherapeutics can be an effective method to help patients suffering from it.
Specific populations are disproportionately affected by mental health disorders. This includes young adults, Hispanics, blacks, vital workers, unpaid caregivers for adults, and those undergoing treatment for preexisting psychiatric conditions.
The key driving aspects of the market are increased risk for psychological distress and unhealthy coping, as well as improved availability of resources for clinical diagnostics and treatment choices such as telemedicine.
Demand for effective treatment of individuals with mental disorders and the delivery of evidence-based mental health services are gaining a lot of traction. Hence, the market of digital psychotherapeutics is expected to witness impressive growth.
Leading companies are launching new software, programs, and services to gain maximum profits. For instance, in April 2021 a new digital mental health program was launched by Starling Minds. It is designed to make engaging and effective digital mental healthcare accessible to employees who are on leave.
Other Drivers Propelling the Demand for Digital Psychotherapeutics include:
Challenges for Companies in the Digital Psychotherapeutics Market:
Opportunities in the Digital Psychotherapeutics Industry:
Latest Trends in the Digital Psychotherapeutics Market:
Attributes | Key Insights |
---|---|
Estimated Global Digital Psychotherapeutics Market Size (2023) | USD 1.06 billion |
Projected Digital Psychotherapeutics Market Value (2033) | USD 12.2 billion |
Value-based CAGR (2023 to 2033) | 27.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights (FMI), the global market for digital psychotherapeutics experienced a CAGR of 26.8% from 2017 to 2022. It is set to be valued at USD 1.06 billion in 2023.
From 2017 to 2022, the global digital psychotherapeutics industry witnessed high growth. The integration of technologies such as virtual reality and augmented reality had significantly impacted the market, especially during the pandemic.
The historical transformation of digital psychotherapeutics has been marked by advancements in technology, increasing accessibility, and a greater emphasis on personalized interventions.
Integration of virtual reality, artificial intelligence, teleconsultation, and remote therapy has significantly expanded the possibilities for delivering mental health care. It has the potential to improve access, affordability, and effectiveness of psychological interventions.
Future Forecast for Digital Psychotherapeutics Industry:
Looking ahead, the global digital psychotherapeutics industry is anticipated to expand at a CAGR of 27.6% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 12.2 billion in 2033.
The global market is anticipated to expand between 2023 and 2033, driven by the adoption of digital platforms and mobile applications as it has gained popularity for delivering psychotherapy interventions.
Factors such as increasing mental health awareness, technological advancements, and the need for accessible mental health services will also contribute to its expansion.
Several companies have developed and marketed their own digital psychotherapy platforms to meet the growing demand. Further, new players have emerged, offering innovative solutions and technologies to cater to specific mental health needs. These developments are positively impacting the market.
Growing Mental Health Awareness Boosting the United States Digital Psychotherapeutics Industry
Country | United States |
---|---|
Market Size (USD billion) by End of Forecast Period (2033) | USD 373.0 million |
CAGR % from 2023 to the End of Forecast (2033) | 18.5% |
The United States digital psychotherapeutics industry is projected to reach a valuation of USD 373.0 million by 2033. From 2023 to 2033, demand for digital psychotherapeutics in the country is likely to rise at 18.5% CAGR.
The digital psychotherapeutics industry in the United States is expected to progress as the country's mental health awareness grows.
Anxiety, depression, and post-traumatic stress disorder (PTSD) are common mental health illnesses in the United States. The growing recognition and understanding of these conditions have led to an increased demand for digital psychotherapeutic services.
Further, the United States has been experiencing a mental health professional shortage, particularly in certain regions. By linking clients with therapists across the country, digital psychotherapy can help overcome this gap.
Government Initiatives to Combat Psychological Health Disorders Propelling Demand in the United Kingdom
Country | The United Kingdom |
---|---|
Market Size (USD billion) by End of Forecast Period (2033) | USD 30.3 million |
CAGR % from 2023 to the End of Forecast (2033) | 26.5% |
As per Future Market Insights (FMI), digital psychotherapeutic demand in the United Kingdom is forecast to surge at 26.5% during the assessment period. Total market value is expected to reach USD 30.3 million by the end of 2033.
Growth in the market is driven by increasing prevalence of mental health disorders and government initiatives in the region.
Individuals who are enduring psychological anguish can benefit from psychological treatments and contribute more to society. As a result, government is launching various initiatives to provide people access to these various treatments.
The Improving Access to Psychological Therapy (IAPT) program of the United Kingdom's National Health Service (NHS) provides psychological therapy. This effort aims to make evidence-based therapies more broadly available, lowering wait times and ensuring people receive the assistance they require as soon as possible.
Technological Advancements in Digital Health Spurring Growth in China’s Digital Psychotherapeutics Industry
Country | China |
---|---|
Market Size (USD billion) by End of Forecast Period (2033) | USD 50.7 million |
CAGR % from 2023 to the End of Forecast (2033) | 37.0% |
China digital psychotherapeutics industry is anticipated to reach a valuation of USD 50.7 million. It is likely to exhibit a CAGR of 37.0% during the forecast period. Growth in the market is driven by robust advancements in telemedicine and digital health technology.
China is well-known for its strong technology infrastructure and high smartphone adoption. Telemedicine, mobile health applications, and wearable gadgets have seen tremendous improvements in the country. This technological readiness has created a favorable environment for the development of digital therapeutics.
People are becoming more at ease with using technology to monitor their health and participate in therapeutic activities. As a result, people in the country are increasingly adopting digital health. This is likely to continue pushing growth in the digital psychotherapeutics industry in China.
Favorable Regulatory Scenarios to Support Expansion of Digital Psychotherapeutics Industry in Japan
Country | Japan |
---|---|
Market Size (USD billion) by End of Forecast Period (2033) | USD 38.1 million |
CAGR % from 2023 to the End of Forecast (2033) | 10.9% |
The digital psychotherapeutics industry in Japan is projected to cross a valuation of USD 38.1 million by 2033. From 2023 to 2033, digital psychotherapeutics sales revenue in the country is expected to rise at 10.9% CAGR. Because of favorable regulatory conditions, Japan market is expected to witness robust growth.
In Japan, the regulatory landscape for digital therapies is changing. The Pharmaceuticals and Medical Devices Agency (PMDA) launched a new regulatory framework for medical devices, including digital therapies, in 2018.
The rules and procedures for obtaining approval and reimbursement for digital therapeutic goods are clarified in this framework. Clear regulations serve to foster an atmosphere conducive to innovation and growth in the industry.
Rising Awareness of Psychological Health to Elevate Digital Therapeutics Demand in Japan
Country | South Korea |
---|---|
Market Size (USD billion) by End of Forecast Period (2033) | USD 16.9 million |
CAGR % from 2023 to the End of Forecast (2033) | 31.7% |
The digital psychotherapeutics industry in South Korea is forecast to reach a valuation of USD 16.9 million by 2033. Over the next ten years, demand for digital therapeutics in the country is set to accelerate at 31.7% CAGR.
The market in South Korea is expected to develop with increasing awareness regarding importance of mental health.
Public awareness campaigns and educational activities have promoted the benefits associated with psychotherapy. This has significantly contributed to an increased demand for psychological services in the region and the trend is expected to continue through 2033.
Combination Therapy to Dominate the Market Through 2033
The combination therapy is expected to dominate the digital psychotherapeutics industry, exhibiting a CAGR of 28.5% from 2023 to 2033. This segment captures a significant market share in 2023 due to its ease of use.
A patient may benefit from in-person psychotherapy sessions enhanced with digital tools or platforms in a combination therapy approach. This involves using smartphone apps for self-monitoring and self-help tools, joining online support groups, or participating in virtual reality-based exposure therapy.
Management to Remain a Highly Profitable Application
Based on application, the market is segmented into prevention, management, and treatment. Among these, management is expected to remain the most remunerative application. It is likely to progress at a CAGR of 27.0% from 2023 to 2033. This is due to the growing recognition of mental health.
Increased demand for psychological therapy management reflects the growing awareness of mental health issues and the need for effective interventions. As societies continue to prioritize mental health, demand for psychological therapy management is predicted to rise. Providers can focus on refining access to these services to deliver improved mental health outcomes to patients.
Direct-to-Patients/Consumers Business Model to Hold a Mammoth Share
As per Future Market Insights (FMI), the direct-to-patients/consumers segment is expected to hold a prominent share of the market by 2033. Further, the target segment is anticipated to exhibit a CAGR of 29.0% from 2023 to 2033. This segment will capture a significant market share due to the demand for accessible and convenient mental health services.
Many individuals face barriers to accessing traditional in-person therapy, such as long wait times, geographical limitations, stigma, and cost. Digital platforms can overcome some of these barriers by offering therapy with more flexibility, affordability, and availability on-demand. Hence, the convenient use of direct-to-consumer model will boost the target segment.
The digital psychotherapeutics industry is becoming highly competitive due to entrance of various new companies. In such a scenario, players must adopt effective strategies to stay ahead of the competition.
Key Strategies Adopted by the Players:
Product Innovation
Companies are focusing on introducing new solutions to differentiate themselves from their competitors and cater to the changing needs of customers. They are also making use of advanced technologies to stay ahead of the competition.
Strategic Partnerships and Collaborations
Key digital psychotherapeutics providers often form strategic partnerships and collaborations with other companies to leverage their strengths and expand their reach in the market.
Expansion into Emerging Markets
Leading digital psychotherapeutics companies are showing inclination towards entering emerging markets such as China and India to gain profits.
Mergers and Acquisitions
Several providers of digital psychotherapeutics are adopting mergers and acquisitions to solidify their market position, expand their product portfolio, and gain access to new markets.
Key Players in the Digital Psychotherapeutics Industry:
Key Developments in the Market:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Attribute | Details |
---|---|
Estimated Market Size (2023) | USD 1.06 billion |
Projected Market Size (2033) | USD 12.2 billion |
Anticipated Growth Rate (2023 to 2033) | 27.6% CAGR |
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2017 to 2022 |
Market Analysis | USD billion for Value and MT for Volume |
Key Regions Covered | North America; Latin America; Europe; Asia Pacific; and Middle East and Africa |
Key Countries Covered | United States, Canada, Mexico, Brazil, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, China, Japan, South Korea, India, ASEAN, Australia and New Zealand, Türkiye, South Africa, GCC Countries, and Others. |
Key Segments Covered | The solution, Application, Business Model, and Region |
Key Companies Profiled | SwissDTx; Starling Minds; Woebot Health; Talkspace; Pear Therapeutics; Ginger; Meru; Spring Care, Inc.; AbleTo, Inc.; Novartis; SilverCloud Health; FlyingPepper; BetterHelp |
The market is valued at USD 1.0 billion in 2023.
SwissDTx, Starling Minds, and Woebot Health are the leading market players.
The market is estimated to reach USD 12.2 billion by 2033.
Technological advancements in clinical evaluation are projected to drive the market prospects.
Combination therapy is likely to remain preferred through 2033.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value-Added Insights 5. Market Background 6. COVID-19 Crisis – Impact Assessment 7. Global Market Demand (in Value or Size in USD Billion) Analysis 2017 to 2022 and Forecast, 2023 to 2033 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Solution 8.1 Monotherapy 8.2 Combination Therapy 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 9.1 Prevention 9.2 Management 9.3 Treatment 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Business Model 10.1 Direct-to-Patients/Consumers 10.2 Business-to-Business (B2B) 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 11.1 North America 11.2 Latin America 11.3 Europe 11.4 East Asia 11.5 South Asia 11.6 Oceania 11.7 Middle East and Africa 12. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19. Market Structure Analysis 20. Competition Analysis 20.1 SwissDTx 20.2 Starling Minds 20.3 Woebot Health 20.4 Talkspace 20.5 Pear Therapeutics 20.6 Ginger 20.7 Meru 20.8 Spring Care, Inc. 20.9 AbleTo, Inc. 20.10 Novartis 20.11 SilverCloud Health 20.12 FlyingPepper 20.13 BetterHelp 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports